Related Experiment Video

Updated: May 13, 2026

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

Fasciculation potentials: a diagnostic biomarker of early ALS?

Andrew Eisen, Steve Vucic

    Journal of Neurology, Neurosurgery, and Psychiatry
    |March 5, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    Keywords:
    ALSMOTOR NEURON DISEASENEUROMUSCULARNEUROPHYSIOL, CLINICALPERIPHERAL NEUROPATHOLOGY

    More Related Videos

    In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
    06:35

    In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

    Published on: June 15, 2018

    Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
    08:59

    Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

    Published on: July 16, 2021

    Related Experiment Videos

    Last Updated: May 13, 2026

    Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
    08:16

    Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

    Published on: March 4, 2014

    In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
    06:35

    In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

    Published on: June 15, 2018

    Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
    08:59

    Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

    Published on: July 16, 2021

    Related Concept Videos

    Myasthenia Gravis: Diagnostic Tests01:15

    Myasthenia Gravis: Diagnostic Tests

    Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
    The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
    Action Potential01:14

    Action Potential

    Neurons communicate by firing action potentials—the electrochemical signal that is propagated along the axon. The signal results in the release of neurotransmitters at axon terminals, thereby transmitting information to the nervous system. An action potential is a specific "all-or-none" change in membrane potential that results in a rapid spike in voltage.
    Membrane potential in neurons
    Neurons typically have a resting membrane potential of about -70 millivolts (mV). When they receive...

    Articles linked to this work by shared authors, journal, and citation graph.

    Gold Coast criteria for ALS diagnosis: individual participant data meta-analysis.

    Journal of neurology·2026

    Cortical excitability stratifies neurochemical profiles in amyotrophic lateral sclerosis.

    Brain communications·2026

    The aging brain that doesn't fail: how neural resilience masks neurodegeneration.

    Amyotrophic lateral sclerosis & frontotemporal degeneration·2026

    A functional framework in patient fibroblasts informs ATP7A variant pathogenicity and identifies p.Q990P as a novel cause of distal motor neuropathy.

    Human molecular genetics·2026

    Muscle Ultrasound Is a Sensitive Outcome Measure in ALS.

    Muscle & nerve·2026

    Strategic Amyotrophic Lateral Sclerosis Australia-Systems Genomics Consortium (SALSA-SGC): cohort profile.

    BMJ open·2026

    Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing.

    Journal of neurology, neurosurgery, and psychiatry·2026

    Balancing Benefits and Risks: Long-term Use of Daily versus Intermittent Corticosteroids in Duchenne Muscular Dystrophy.

    Journal of neurology, neurosurgery, and psychiatry·2026

    Epilepsy and education: a nationwide cohort study.

    Journal of neurology, neurosurgery, and psychiatry·2026

    Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

    Journal of neurology, neurosurgery, and psychiatry·2026

    Iatrogenic cerebral amyloid angiopathy: a scoping review.

    Journal of neurology, neurosurgery, and psychiatry·2026

    Associations of self-reported and objectively measured physical activity and amyotrophic lateral sclerosis risk.

    Journal of neurology, neurosurgery, and psychiatry·2026

    The Prevalence of Neuropathic Pain in Multiple Sclerosis-A Systematic Review and Meta-Analysis Using the NeuPSIG Algorithm.

    European journal of pain (London, England)·2026

    Mitophagy in neuronal health and disease: from mechanisms to neurodegeneration.

    The Journal of clinical investigation·2026

    The Association Between NT-Pro BNP, Nephropathy and Endothelial Dysfunction in Patients With Type 2 Diabetes Mellitus.

    Diabetes, obesity & metabolism·2026

    Concurrent sigmoid volvulus and caecal adenocarcinoma in a paraplegic patient with neurogenic bowel: a case report.

    Journal of surgical case reports·2026

    Comparative Efficacy of Invasive and Non-Invasive Neuromodulation Techniques for Chronic Central and Peripheral Neuropathic Pain: A Systematic Review and Network Meta-Analysis.

    Journal of pain research·2026

    Predicting disease progression in progressive cerebellar ataxias: integrating clinical, imaging, fluid, genetic, and digital biomarkers.

    Frontiers in neurology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us